CareDx PE Ratio 2013-2025 | CDNA

Current and historical p/e ratio for CareDx (CDNA) from 2013 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CareDx PE ratio as of June 10, 2025 is 17.15.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

CareDx PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-10 19.85 17.26
2025-03-31 17.75 $1.15 15.43
2024-12-31 21.41 $1.02 20.99
2024-09-30 31.23 $-2.70 0.00
2024-06-30 15.53 $-2.99 0.00
2024-03-31 10.59 $-3.42 0.00
2023-12-31 12.00 $-3.54 0.00
2023-09-30 7.00 $-1.67 0.00
2023-06-30 8.50 $-1.56 0.00
2023-03-31 9.14 $-1.51 0.00
2022-12-31 11.41 $-1.44 0.00
2022-09-30 17.02 $-1.41 0.00
2022-06-30 21.48 $-1.32 0.00
2022-03-31 36.99 $-0.95 0.00
2021-12-31 45.48 $-0.59 0.00
2021-09-30 63.37 $-0.35 0.00
2021-06-30 91.52 $-0.18 0.00
2021-03-31 68.09 $-0.29 0.00
2020-12-31 72.45 $-0.42 0.00
2020-09-30 37.94 $-0.46 0.00
2020-06-30 35.43 $-0.44 0.00
2020-03-31 21.83 $-0.48 0.00
2019-12-31 21.57 $-0.52 0.00
2019-09-30 22.61 $-0.50 0.00
2019-06-30 35.99 $-1.00 0.00
2019-03-31 31.52 $-1.21 0.00
2018-12-31 25.14 $-1.33 0.00
2018-09-30 28.85 $-2.37 0.00
2018-06-30 12.24 $-2.46 0.00
2018-03-31 7.97 $-2.25 0.00
2017-12-31 7.34 $-2.21 0.00
2017-09-30 3.70 $-1.81 0.00
2017-06-30 1.11 $-1.44 0.00
2017-03-31 1.40 $-2.01 0.00
2016-12-31 2.70 $-2.56 0.00
2016-09-30 3.55 $-2.23 0.00
2016-06-30 4.31 $-2.26 0.00
2016-03-31 4.96 $-1.77 0.00
2015-12-31 6.40 $-1.15 0.00
2015-09-30 4.17 $-0.75 0.00
2015-06-30 6.50 $-0.34 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $1.098B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.561B 26.74
Elevance Health (ELV) United States $88.026B 11.36
CVS Health (CVS) United States $80.784B 10.04
Cencora (COR) United States $55.036B 19.15
DiDi Global (DIDIY) China $23.580B 35.79
Natera (NTRA) United States $22.420B 0.00
BioMerieux (BMXMF) France $16.097B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.007B 0.00
Solventum (SOLV) United States $12.962B 13.72
CochLear (CHEOY) Australia $11.342B 0.00
ICON (ICLR) Ireland $11.283B 10.49
Revvity (RVTY) United States $10.948B 18.84
Doximity (DOCS) United States $10.905B 50.49
Viatris (VTRS) United States $10.340B 3.55
HealthEquity (HQY) United States $9.613B 42.11
Avantor (AVTR) United States $9.165B 13.32
Medpace Holdings (MEDP) United States $8.574B 22.77
Sonic Healthcare (SKHHY) Australia $8.388B 0.00
Charles River Laboratories (CRL) United States $7.243B 14.19
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.238B 24.96
BrightSpring Health Services (BTSG) United States $4.157B 38.48
Sotera Health (SHC) United States $3.508B 19.93
Surgery Partners (SGRY) United States $2.994B 38.93
Alignment Healthcare (ALHC) United States $2.924B 0.00
Concentras Parent (CON) United States $2.830B 16.36
Organon (OGN) United States $2.537B 2.70
GeneDx Holdings (WGS) United States $2.066B 79.58
Ardent Health Partners (ARDT) United States $1.957B 8.34
Premier (PINC) United States $1.900B 14.43
Progyny (PGNY) United States $1.883B 41.45
PACS (PACS) United States $1.586B 0.00
GoodRx Holdings (GDRX) United States $1.468B 29.36
Teladoc Health (TDOC) United States $1.298B 0.00
Pediatrix Medical (MD) United States $1.214B 9.24
Establishment Labs Holdings (ESTA) $1.113B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.944B 0.00
AMN Healthcare Services Inc (AMN) United States $0.818B 7.66
QDM (QDMI) Hong Kong, SAR China $0.752B 0.00
Nutex Health (NUTX) United States $0.654B 9.90
Embecta (EMBC) United States $0.579B 3.90
LifeMD (LFMD) United States $0.566B 0.00
Enhabit (EHAB) United States $0.546B 44.92
InnovAge Holding (INNV) United States $0.520B 0.00
SBC Medicals (SBC) United States $0.507B 0.00
Sonida Senior Living (SNDA) United States $0.472B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.60
COMPASS Pathways (CMPS) United Kingdom $0.437B 0.00
Performant Healthcare (PHLT) United States $0.244B 0.00
Oncology Institute (TOI) United States $0.232B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
DocGo (DCGO) United States $0.163B 26.67
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.099B 0.00
So-Young (SY) China $0.091B 0.00
Basel Medical Group (BMGL) Singapore $0.081B 0.00
KindlyMD (NAKA) United States $0.081B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Sera Prognostics (SERA) United States $0.057B 0.00
ModivCare (MODV) United States $0.050B 0.00
Biodesix (BDSX) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00